Project – Impact of Malaria Parasitaemia on Fetal and Placental Outcomes Among Pregnant Women

CHAPTER ONE

INTRODUCTION

1.1 Background of the Study

Malaria remains a major public health concern globally, particularly in sub-Saharan Africa where the disease burden is highest. According to the World Health Organization, Nigeria accounts for a significant proportion of global malaria cases and deaths, with pregnant women and children under five being the most vulnerable groups. Malaria in pregnancy is predominantly caused by Plasmodium falciparum, a parasite known for its ability to adhere to vascular endothelium and accumulate in the placenta, leading to a condition known as placental malaria.

Pregnancy induces immunological and physiological changes that reduce a woman’s immunity to malaria infection. This increased susceptibility is particularly pronounced among primigravidae (first-time mothers), who lack sufficient pregnancy-specific immunity. As a result, malaria parasitaemia—the presence of malaria parasites in the blood—occurs more frequently and with greater severity in pregnant women compared to non-pregnant women living in the same endemic regions.

Placental malaria occurs when infected erythrocytes accumulate in the intervillous spaces of the placenta, triggering inflammatory responses that impair placental function. This condition disrupts the transfer of oxygen and essential nutrients from mother to fetus, leading to adverse fetal outcomes such as intrauterine growth restriction, low birth weight, preterm delivery, and increased risk of neonatal mortality. Studies have shown that placental parasitaemia is strongly associated with poor perinatal outcomes and remains a leading cause of preventable neonatal morbidity in malaria-endemic regions (Desai et al., 2007).

Furthermore, malaria parasitaemia during pregnancy has been linked to maternal anaemia, which further exacerbates fetal complications. Anaemia reduces oxygen-carrying capacity, thereby compounding the effects of placental insufficiency. The combined effect of maternal parasitaemia and anaemia creates a high-risk environment for fetal development.

In addition to fetal outcomes, malaria infection during pregnancy has significant implications for placental health. Placental parasitaemia not only reflects active infection but also serves as a reservoir for parasites that can persist even when peripheral blood smears are negative. This makes it a critical indicator for assessing the severity and chronicity of malaria infection in pregnancy.

Preventive strategies such as intermittent preventive treatment in pregnancy (IPTp), insecticide-treated nets (ITNs), and early antenatal care attendance have been promoted to reduce the burden of malaria in pregnancy. Despite these interventions, malaria parasitaemia and its associated complications remain prevalent in many parts of Nigeria due to factors such as poor compliance, late booking, limited access to healthcare, and socio-economic challenges.

In healthcare institutions such as Federal Medical Centre Owerri, pregnant women receive antenatal care services that include malaria screening and preventive interventions. However, the persistence of adverse fetal and placental outcomes suggests that malaria parasitaemia continues to have a significant impact on pregnancy outcomes in this setting.

Previous studies have documented associations between malaria parasitaemia and adverse birth outcomes, but there is still a need for context-specific research that evaluates both fetal and placental outcomes simultaneously. Understanding this relationship is essential for improving maternal healthcare interventions and reducing the burden of malaria-related complications.

Therefore, this study aims to investigate the impact of malaria parasitaemia on fetal and placental outcomes among pregnant women attending antenatal care at Federal Medical Centre Owerri.

1.2 Statement of the Problem

Malaria parasitaemia during pregnancy continues to be a major contributor to adverse maternal and neonatal health outcomes in Nigeria. Despite ongoing efforts to control malaria through preventive and therapeutic interventions, the prevalence of malaria infection among pregnant women remains unacceptably high.

One of the most concerning aspects of malaria in pregnancy is its impact on fetal and placental health. Malaria parasites can accumulate in the placenta, leading to placental insufficiency and impaired fetal development. This often results in complications such as low birth weight, preterm delivery, intrauterine growth restriction, and increased neonatal mortality. These outcomes not only affect immediate neonatal survival but also have long-term consequences on child health and development.

In many healthcare settings, including Federal Medical Centre Owerri, cases of adverse pregnancy outcomes associated with malaria are still being reported. This raises concerns about the effectiveness of current preventive measures and highlights the need for a deeper understanding of the relationship between malaria parasitaemia and pregnancy outcomes.

Moreover, while some pregnant women may test negative for malaria in peripheral blood, parasites may still be present in the placenta, making diagnosis and management more challenging. This hidden burden of placental malaria often goes undetected, contributing to poor fetal outcomes despite apparent maternal health.

Another critical issue is the lack of comprehensive data linking malaria parasitaemia at different stages of pregnancy to specific fetal and placental outcomes within the local context. Without such data, healthcare providers may find it difficult to implement targeted interventions or evaluate the effectiveness of existing strategies.

Additionally, socio-demographic factors such as age, parity, and timing of antenatal booking may influence the severity and outcomes of malaria infection, yet these factors are not always adequately considered in clinical management.

Given these challenges, there is a pressing need to investigate the impact of malaria parasitaemia on fetal and placental outcomes among pregnant women. This study seeks to fill this gap by providing empirical evidence from Federal Medical Centre Owerri, thereby contributing to improved maternal and child health strategies.

1.3 Objectives of the Study

The main objective of this study is to examine the impact of malaria parasitaemia on fetal and placental outcomes among pregnant women.

The specific objectives are to:

1. Determine the prevalence of malaria parasitaemia among pregnant women.
2. Assess the relationship between malaria parasitaemia and fetal outcomes such as low birth weight and preterm delivery.
3. Evaluate the association between malaria parasitaemia and placental parasitaemia.
4. Examine the influence of maternal factors (age, parity, antenatal booking) on malaria parasitaemia and outcomes.

1.4 Research Questions

1. What is the prevalence of malaria parasitaemia among pregnant women?
2. What relationship exists between malaria parasitaemia and fetal outcomes?
3. How does malaria parasitaemia affect placental health?
4. What maternal factors influence malaria parasitaemia and its outcomes?

1.5 Research Hypothesis

H₀: Malaria parasitaemia has no significant impact on fetal and placental outcomes among pregnant women.

1.6 Significance of the Study

This study will provide valuable insights into the effects of malaria parasitaemia on pregnancy outcomes. It will benefit healthcare providers by improving clinical decision-making, assist policymakers in designing effective malaria control programs, and contribute to academic knowledge in maternal and child health research.

1.7 Scope of the Study

This study focuses on pregnant women attending antenatal care at Federal Medical Centre Owerri. It examines the impact of malaria parasitaemia on fetal and placental outcomes within this population.

1.8 Definition of Terms

• Malaria Parasitaemia: Presence of malaria parasites in the bloodstream.
• Placental Parasitaemia: Presence of malaria parasites in placental tissue.
• Low Birth Weight (LBW): Birth weight less than 2.5 kg.
• Preterm Delivery: Delivery before 37 weeks of gestation.
• Fetal Outcome: Health condition of the baby at birth.

Project – Impact of Malaria Parasitaemia on Fetal and Placental Outcomes Among Pregnant Women